Impetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

Hevolution Foundation and Rosenkranz Foundation to contribute $5 Million each


SAN FRANCISCO–(BUSINESS WIRE)–Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding. Hevolution Foundation, a global non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, is contributing $5 million to Impetus Grants. Rosenkranz Foundation, founded by Robert Rosenkranz, an American philanthropist and a Board member of the Buck Institute and an honorary Fellow of the Academy for Health and Lifespan Research, is joining the round with a $5 million contribution.

Since its founding in 2021, Impetus Grants has deployed more than $24 million into aging-related scientific research, supporting a number of aging-related clinical trials, biomarkers, novel tools and model organisms. The previous rounds of Impetus Grants have already generated more than a dozen published papers, including some which have been recognized as important breakthroughs in the field. With this new funding from Hevolution Foundation and Rosenkranz Foundation, Impetus will expand its efforts to fund high-risk, high-reward science in aging.

“Following our matching funding for Impetus last year, we are very pleased to again work with the organization to fund cutting-edge healthspan-related research,” stated Hevolution Foundation’s CEO Dr. Mehmood Khan. “We were pleased with the depth and breadth of the research programs that were funded via that program, and are confident that this effort will be even more impactful.”

“We hope these grants will lead to important discoveries and will accelerate the careers of some of our most brilliant scientists,” commented Mr. Rosenkranz. “We believe we are on the cusp of learning how human healthspans can be extended for a decade or more, and that succeeding will be perhaps the greatest contribution science can make to human flourishing.”

The round has been announced on Impetus Grants website and will open on August 1st, 2023.

About Impetus Grants

Established in 2021, Impetus Grants is dedicated to supporting innovative ideas in the aging space that might otherwise be overlooked by traditional funders. The organization has successfully deployed over $24 million into scientific research projects, including aging-related clinical trials, biomarker research, and the development of novel tools and model organisms related to the aging process.

Contacts

Contact for Impetus Grants:
[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.